Dear Researchers,

The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Szűcs Zsolt

University of Debrecen Faculty of Pharmacy

Department of Pharmaceutical Chemistry

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2015-2022

2022

Szűcs, Z., Bereczki, I., Fenyvesi, F., Herczegh, P., Ostorházi, E., Borbás, A.: Synthesis of an amphiphilic vancomycin aglycone derivative inspired by polymyxins: overcoming glycopeptide resistance in Gram-positive and Gram-negative bacteria in synergy with teicoplanin in vitro.
Sci. Rep. 12 (1), 1-14, (article identifier: 20921), 2022.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

Bereczki, I., Szűcs, Z., Batta, G., Nagy, T. M., Ostorházi, E., Kövér, K. E., Borbás, A., Herczegh, P.: The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin.
Pharmaceuticals (Basel). 15 (1), 1-17, (article identifier: 77), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

2021

Vimberg, V., Zieglerova, L., Mazumdar, A., Szűcs, Z., Borbás, A., Herczegh, P., Balikova Novotna, G.: Two Novel Semisynthetic Lipoglycopeptides Active against Staphylococcus aureus Biofilms and Cells in Late Stationary Growth Phase.
Pharmaceuticals (Basel). 14 (11), 1-12, 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

2020

Szűcs, Z., Bereczki, I., Rőth, E., Milánkovits, M., Ostorházi, E., Batta, G., Nagy, L., Dombrádi, Z. R., Borbás, A., Herczegh, P.: N-Terminal guanidine derivatives of teicoplanin antibiotics strongly active against glycopeptide resistant Enterococcus faecium.
J. Antibiot. 73 (9), 603-614, 2020.

doi DEA

Journal metrics:

Q3 Drug Discovery

Q3 Pharmacology

Szűcs, Z., Naesens, L., Stevaert, A., Ostorházi, E., Batta, G., Herczegh, P., Borbás, A.: Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity.
Pharmaceuticals (Basel). 13 (7), 1-15, 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery

Q2 Molecular Medicine

D1 Pharmaceutical Science

Bereczki, I., Csávás, M., Szűcs, Z., Rőth, E., Batta, G., Ostorházi, E., Naesens, L., Borbás, A., Herczegh, P.: Synthesis of Antiviral Perfluoroalkyl Derivatives of Teicoplanin and Vancomycin.
ChemMedChem. 15 (17), 1661-1671, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Drug Discovery

Q3 Molecular Medicine

Q2 Organic Chemistry

Q2 Pharmacology

Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

2019

Szűcs, Z., Ostorházi, E., Kicsák, M., Nagy, L., Borbás, A., Herczegh, P.: New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE.
J. Antibiot. 72 (7), 524-534, 2019.

doi DEA WoS Scopus

Journal metrics:

Q2 Drug Discovery

Q3 Pharmacology

Tevyashova, A. N., Bychkova, E. N., Korolev, A. M., Isakova, E. B., Mirchink, E. P., Osterman, I. A., Erdei, R., Szűcs, Z., Batta, G.: Synthesis and evaluation of biological activity for dual-acting antibiotics on the basis of azithromycin and glycopeptides.
Bioorg. Med. Chem. Lett. 29 (2), 276-280, 2019.

doi DEA WoS Scopus

Journal metrics:

Q3 Biochemistry

Q2 Clinical Biochemistry

Q2 Drug Discovery

Q3 Molecular Biology

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

2018

Vimberg, V., Gazak, R., Szűcs, Z., Borbás, A., Herczegh, P., Cavanagh, J. P., Zieglerova, L., Závora, J., Adámková, V., Balikova Novotna, G.: Fluorescence assay to predict activity of the glycopeptide antibiotics.
J. Antibiot. 72 (2), 114-117, 2018.

doi DEA

Journal metrics:

Q2 Drug Discovery

Q2 Pharmacology

10.

Szűcs, Z., Kelemen, V., Le Thai, S., Csávás, M., Rőth, E., Batta, G., Stevaert, A., Vanderlinden, E., Naesens, L., Herczegh, P., Borbás, A.: Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.
Eur. J. Med. Chem. 157, 1017-1030, 2018.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery

Q1 Medicine (miscellaneous)

Q1 Organic Chemistry

Q1 Pharmacology

2017

11.

Szűcs, Z., Bereczki, I., Csávás, M., Rőth, E., Borbás, A., Batta, G., Ostorházi, E., Szatmári, R., Herczegh, P.: Lipophilic teicoplanin pseudoaglycon derivatives are active against vancomycin- and teicoplanin-resistant enterococci.
J. Antibiot. 70 (5), 664-670, 2017.

doi DEA WoS Scopus

Journal metrics:

Q2 Drug Discovery

Q2 Pharmacology

12.

Szűcs, Z., Csávás, M., Rőth, E., Borbás, A., Batta, G., Perret, F., Ostorházi, E., Szatmári, R., Vanderlinden, E., Naesens, L., Herczegh, P.: Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function.
J. Antibiot. 70 (2), 152-157, 2017.

doi DEA WoS Scopus

Journal metrics:

Q2 Drug Discovery

Q2 Pharmacology

2015

13.

Csávás, M., Miskovics, A., Szűcs, Z., Rőth, E., Nagy, Z. L., Bereczki, I., Herczeg, M., Batta, G., Nemes-Nikodém, É., Ostorházi, E., Rozgonyi, F., Borbás, A., Herczegh, P.: Synthesis and antibacterial evaluation of some teicoplanin pseudoaglycon derivatives containing alkyl- and arylthiosubstituted maleimides.
J. Antibiot. 68 (9), 579-585, 2015.

doi DEA

Journal metrics:

Q2 Drug Discovery

Q2 Pharmacology